In Vitro Activity of Sulbactam–Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates: A Multicentre Report from Italy
In the present study, the in vitro activity of the sulbactam–durlobactam (SUL–DUR) combination was evaluated against 141 carbapenem-resistant <i>A. baumannii</i> (CR<i>Ab</i>) clinical strains collected from six Italian laboratories. Over half (54.6%) of these isolates were resistant to colistin. Th...
שמור ב:
| Principais autores: | , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2022-08-01
|
| סדרה: | Antibiotics |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/2079-6382/11/8/1136 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
